
Stem Cells for Anoxic Brain Injury: Does Timing Matter?
Key Takeaways Stem cell therapy for anoxic brain injury is still experimental, and no study has compared early with late treatment in people. Most natural recovery after cardiac arrest occurs
Home » Blog

Key Takeaways Stem cell therapy for anoxic brain injury is still experimental, and no study has compared early with late treatment in people. Most natural recovery after cardiac arrest occurs

Key Takeaways Stem cells for psoriasis remain experimental, and the human evidence comes from very small studies. Cochrane’s living review found that biologic medicines cleared skin better than older tablets

Key Takeaways A Japanese health ministry panel backed full approval of Stemirac, a bone marrow cell therapy, on 15 October 2026. Reported data compared 73 treated patients with 66 untreated

Key Takeaways Stem cell therapy for cerebral palsy is still experimental and is not established standard care. A 2021 randomized trial of 72 children reported higher motor scores 12 months

Key Takeaways Mesenchymal stem cells are among the most studied cell types for chronic liver disease, but the approach is still experimental. Researchers think the cells may calm the immune

Key Takeaways A phase 2b trial gave 148 adults aged 70 to 85 one infusion of donated mesenchymal stem cells or placebo. At nine months, the 200 million cell group